- ►annals.org [PDF] RM Jasmer, JJ Saukkonen, HM Blumberg, CL … - Annals of internal medicine, 2002 - Am Coll Physicians Background: Rifampin and pyrazinamide are recommended for treatment of latent
tuberculosis infection in adults without HIV infection, but reports of severe
hepatotoxicity have raised concerns about its safety. Clinical trials have ... Cited by 111 - Related articles - All 6 versions
- ►atsjournals.org JE Stout, JJ Engemann, AC Cheng, ER … - American journal of respiratory and critical care …, 2003 - Am Thoracic Soc An alternative regimen for the treatment of latent tuberculosis infection is 2
months of rifampin and pyrazinamide, but some patients have died of hepatitis
associated with this therapy. One hundred fourteen patients received ... Cited by 54 - Related articles - BL Direct - All 10 versions
L McNeill, M Allen, C Estrada, P Cook - Chest, 2003 - chestjournal.chestpubs.org Context: American Thoracic Society guidelines recommend a 9-month course of
therapy with isoniazid for treatment of persons with latent tuberculosis
infection who are at high risk for reactivation of disease. Major liver ... Cited by 77 - Related articles - BL Direct - All 7 versions
NN Bock, T Rogers, JR Tapia, GD Herron, B … - Chest, 2001 - chestjournal.chestpubs.org Study objectives: To determine whether short-course treatment of latent
tuberculosis infection (LTBI) with 2 months of rifampin and pyrazinamide (2RZ)
is well tolerated and leads to increased treatment completion among jail ... Cited by 51 - Related articles - BL Direct - All 5 versions
RE Chaisson, J Armstrong, J Stafford, J Golub … - JAMA, 2002 - Am Med Assoc From December 1, 1999 through June 30, 2001, inmates of the Maryland Department
of Public Safety and Correctional Services (DPSCS) who had a reactive tuberculin
skin test (defined as 5 mm), no radiographic evidence of active TB, and ... Cited by 25 - Related articles - All 5 versions
CM Nolan, SV Goldberg, SE Buskin - Jama, 1999 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 250 - Related articles - BL Direct - All 5 versions
- ►pracaonze.org [PDF] F Gordin, RE Chaisson, JP Matts, C Miller, ML … - Jama, 2000 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 204 - Related articles - BL Direct - All 9 versions
- ►171.66.122.149 PA LoBue, KS Moser - American journal of respiratory and critical care …, 2003 - 171.66.122.149 Isoniazid is an efficacious treatment for latent tuberculosis. Concerns remain,
however, regarding hepatotoxicity associated with this medication. In addition,
adherence may be suboptimal because at least 6 months of treatment is ... Cited by 79 - Related articles - BL Direct - All 8 versions
- ►idsociety.org [PDF] FM Gordin, DL Cohn, JP Matts, RE Chaisson, … - Clinical Infectious Diseases, 2004 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 38 - Related articles - BL Direct - All 14 versions
